Our Technology
Osmodex® Technology Family
The Osmodex® family of proprietary technologies combines laser drilled tablet technology with variety of single active and multiple active drug delivery devices. Osmodex® systems simplify dosing and aid in patient compliance. Osmodex® technologies can be divided into the following categories of application:
Osmodex® ID delivery for insoluble drugs
This platform provides flexible delivery options for insoluble drugs. It can accommodate first order, zero order or delayed release options while assuring full release over the targeted timeframe. This technology has been used to solve multiple challenging insoluble drug delivery problems (Example - Osmotica Nifedipine Extended-release Tablets).
Osmodex® SD delivery for soluble drugs
This platform technology can be used to resolve delivery challenges of soluble low-bioavailability
drugs or drugs requiring targeted delivery.
Osmodex® IR/CR combination
This platform technology provides a combination of immediate release and controlled release of either one or two drugs. This innovative approach allows an immediate release profile to be safely and uniformly combined with a programmed release according to the pharmacokinetic or pharmacodynamic needs of the product (Example - Allegra-D® 24 Hour Tablet*).
Duodex™ Double CR combination
This dual controlled release platform allows delivery of two drugs from a single osmotic tablet where each drug release pattern can be independently tailored to the desired release profile.
Osmodex® Triple combination tablet
This delivery system incorporates compressed drug layers around an osmotic core. This combination provides the benefits of immediate release and controlled release delivery, along with the unique benefits of an osmotic controlled release to achieve three different release rates in the same tablet.
* Allegra-D® is a registered trademark of Sanofi-Aventis U.S. LLC